HRT After Hysterectomy: 11 Myths and What the Evidence Really Shows

ByThe PartialHysterectomy.net Editor

Few treatments have a worse reputation than hormone replacement therapy, and few reputations are built on such a tangle of old headlines, half-remembered studies and marketing. If you have had a hysterectomy, much of what you have heard about HRT may not even apply to you: most of the frightening findings came from women who still had a uterus and took a different kind of therapy. This article goes through the most common myths one by one and sets out what the research actually shows, including the risks that are real.

If you first want the basics of what happens to your hormones after each type of surgery, start with our guide to hysterectomy and hormones.

First, a quick word on names

HRT (hormone replacement therapy), MHT (menopausal hormone therapy) and HT (hormone therapy) all mean the same thing: medicines that replace some of the estrogen your ovaries no longer make, sometimes with a progestogen added. Doctors in the United States now tend to say “hormone therapy,” but this article uses HRT because it is the term most people search for. “Estrogen-only” or “estrogen alone” therapy means estrogen with no progestogen, which is what most women without a uterus are offered.

Myth 1: “Everyone needs HRT after a hysterectomy”

Fact: it depends on your ovaries, your age and your symptoms. Removing the uterus does not, by itself, cause menopause, because the ovaries, not the uterus, make your estrogen. If you kept your ovaries and feel well, there is nothing to replace. You will go through menopause naturally later, and at that point the same choices apply as for any woman. Our guide to menopause after hysterectomy with ovaries intact explains how to recognize it without periods.

The picture is different if both ovaries were removed before natural menopause. That causes surgical menopause, and for these women the North American Menopause Society (now The Menopause Society) recommends hormone therapy at least until around the average age of natural menopause, about 51, unless there is a medical reason not to take it.[1] The aim is not only to ease symptoms but to protect bones, heart and brain during the years the ovaries would normally have kept working.

Myth 2: “You always need progesterone with estrogen”

Fact: without a uterus, estrogen alone is usually enough. A progestogen is added to estrogen for one main reason: to stop the lining of the uterus from overgrowing, which can lead to endometrial cancer. With no uterus, there is no lining to protect, so most women after a hysterectomy are prescribed estrogen on its own.[1][15]

There are two common exceptions, so check with your doctor:

  • Endometriosis. Patches of endometriosis left in the pelvis can be stimulated by estrogen alone, so some doctors add a progestogen, at least for a time. Our article on hysterectomy for endometriosis covers this in more detail.
  • Subtotal (supracervical) hysterectomy. If the cervix was left in place, a small amount of lining tissue can remain at its top. If you have any bleeding on estrogen, your doctor may add a progestogen. Our comparison of partial vs total hysterectomy explains which operation you may have had.

This difference matters a great deal, because most of the worrying research results described below came from combined estrogen and progestogen therapy, not from estrogen alone.

Myth 3: “HRT causes breast cancer”

Fact: for estrogen alone after a hysterectomy, the evidence is mixed, and the best trial actually showed fewer breast cancers.

The Women’s Health Initiative (WHI) ran two large randomized trials. One gave women who had had a hysterectomy either estrogen alone or a placebo. After more than 20 years of follow-up, the estrogen group had fewer breast cancers (about 30 per 10,000 women per year, compared with 37 on placebo) and fewer deaths from breast cancer.[5] The other trial, in women with a uterus who took estrogen plus a progestogen, found the opposite: more breast cancers than placebo.[5]

Observational studies tell a somewhat different story. A large 2019 analysis that pooled data from dozens of studies worldwide found that every type of systemic HRT was linked to some extra breast cancer risk, which grew with longer use. The extra risk was much smaller with estrogen alone than with combined therapy, and low-dose vaginal estrogen was not linked to any extra risk.[6] If the link is causal, the researchers estimated that 5 years of estrogen alone starting at 50 would cause about one extra breast cancer for every 200 women by age 69, and 10 years about twice that. For combined therapy with a daily progestogen, the figure was about one in 50.[6]

Why the difference? Randomized trials are better at ruling out other explanations, but the WHI used one specific older estrogen (conjugated equine estrogens, in tablet form) in women who were, on average, 63 when they started. Observational studies include more women, more types of HRT and longer use, but cannot fully separate the effect of the hormones from everything else about the women who choose them. The honest summary: estrogen alone after a hysterectomy carries, at most, a small change in breast cancer risk, and may carry none.

If you have had breast cancer yourself, or carry a gene change such as BRCA, the advice is different and needs a specialist conversation.

Myth 4: “The big study proved HRT causes heart attacks and early death”

Fact: age and timing change the picture, and HRT did not shorten life in the long run.

When the WHI results were first announced in 2002, they were reported as if they applied to every woman. But the average participant was in her sixties, many were well past menopause, and the early alarm came mainly from the combined estrogen-plus-progestogen trial. Later analyses showed:

  • No effect on overall survival. After 18 years of follow-up, women who had taken hormones were no more likely to have died than those on placebo, from any cause, from heart disease or from cancer. For estrogen alone, the result leaned slightly toward fewer deaths, though not by a statistically clear margin.[4]
  • Younger women fared better. In the estrogen-alone trial, women who started in their fifties had fewer serious health events overall than those on placebo, while women who started in their seventies had more.[3]
  • Heart disease was not increased with estrogen alone. Rates of coronary heart disease were similar with estrogen and placebo.[2][3]

A Cochrane review that combined 19 trials found the same pattern. Women who started hormone therapy within 10 years of menopause had lower death rates and less coronary heart disease than those on placebo or no treatment, although they still had more blood clots. Women who started more than 10 years after menopause gained no heart benefit and had more strokes and clots.[7]

The real risks. None of this means HRT is risk-free. In the WHI estrogen-alone trial, estrogen tablets raised the risk of stroke by about 40%, and blood clots were more common than on placebo.[2] These risks are small in absolute terms for healthy women in their fifties, but they are real and they rise with age. That is why guidelines say the benefits usually outweigh the risks for women under 60 or within 10 years of menopause, and why the balance needs more thought after that.[1]

Myth 5: “The FDA warning on the box shows how dangerous it is”

Fact: the FDA has removed most of that warning. For more than 20 years, estrogen products in the United States carried a “black box” warning about heart disease, breast cancer and dementia, largely based on the early WHI results. In November 2025 the FDA announced that it would remove those three risks from the boxed warning, after reviewing the evidence and holding an expert panel.[13] In February 2026 it approved the first updated labels, and noted that starting hormone therapy within 10 years of menopause, generally before age 60, is linked to lower overall mortality and fewer fractures.[14]

Two points are worth knowing. First, the risks have not disappeared from the label: they are still described in the warnings section, just not in the box. Second, the FDA kept the boxed warning about endometrial (uterine) cancer for estrogen-alone products.[13] That warning is about women who still have a uterus and take estrogen without a progestogen. It does not apply once your uterus has been removed, which is exactly why you were prescribed estrogen alone. Your pharmacy leaflet may still be an older version for some time.

Myth 6: “All forms of HRT carry the same risks”

Fact: how estrogen enters your body changes the risk of blood clots. Estrogen comes as tablets, skin patches, gels and sprays, and as low-dose vaginal creams, tablets and rings.

Tablets pass through the liver first, which raises the production of clotting factors. In a UK study of more than 80,000 women with blood clots in the veins, oral estrogen-only HRT was linked to about a 40% higher risk of clots than no HRT, while patches, gels and sprays were not linked to any increase.[8] For a woman with a higher risk of clots, for example because of obesity or a past clot in the family, a skin preparation is usually the safer choice.

Smiling woman in her fifties rubbing a cream into her forearm and elbow in a bright bathroom with a stone sink and unbranded bottles
Rubbing a cream into the arm. Estrogen gels and sprays are used the same way: applied to clean, dry skin, usually on the arm or thigh, and absorbed through it, so they avoid the first pass through the liver.

Low-dose vaginal estrogen is different again. It treats vaginal dryness, pain with sex and some bladder symptoms, with very little reaching the rest of the body. It was not linked to extra breast cancer risk in the large 2019 analysis,[6] and it can be used on its own or alongside other HRT. Our guide to sex after hysterectomy covers vaginal dryness and its treatments.

Myth 7: “Bioidentical hormones from a compounding pharmacy are safer and more natural”

Fact: “bioidentical” is mostly a marketing term, and custom-mixed hormones have less safety testing, not more.

“Bioidentical” simply means the hormone has the same chemical structure as the one your body makes. Many standard, FDA-approved products already contain bioidentical estradiol, in patches, gels, sprays and tablets, and are covered by most insurance plans. The term is often used, though, to sell “compounded” hormones: custom mixtures made up by a pharmacy, sometimes as creams, troches or implanted pellets, and often dosed according to saliva or blood tests.

These compounded products are not FDA-approved, so their strength, purity and absorption are not checked in the same way. A 2020 report from the National Academies of Sciences, Engineering, and Medicine, commissioned by the FDA, found too little evidence to support their benefits and recommended limiting their use to people who cannot use an approved product, for example because of an allergy to an ingredient.[11] The American College of Obstetricians and Gynecologists advises against prescribing them routinely when FDA-approved options exist.[10] Hormone pellets, placed under the skin, are a particular concern: safety data are lacking and they cannot be removed once implanted.[10]

Myth 8: “HRT makes you gain weight”

Fact: trials have not found that HRT adds weight. Many women gain weight in midlife, and it is natural to blame a new medicine. But a Cochrane review of randomized trials found no evidence that estrogen alone, or estrogen with a progestogen, changed body weight beyond what normally happens at menopause. It also did not prevent that midlife gain.[12] Our article on weight gain or weight loss after hysterectomy looks at what does make a difference.

Myth 9: “You have to stop HRT after five years”

Fact: there is no fixed cut-off. The Menopause Society’s 2022 position statement says that treatment should be individualized, with the benefits and risks of continuing reviewed regularly, and that HRT does not need to be stopped routinely at a set age, such as 60 or 65.[1] Some women stop after a few years when symptoms have settled; others, especially those with ongoing hot flashes or a high risk of fractures, continue for longer with their doctor’s agreement, often at the lowest dose that works.

Women who had surgical menopause young are a special case: guidelines suggest continuing at least until around 51, the average age of natural menopause, before deciding whether to go on.[1]

Myth 10: “If you did not start right after surgery, it is too late”

Fact: there is a window, but it is measured in years, not weeks. Guidelines describe the most favorable balance for women under 60 or within 10 years of menopause.[1] If you had your ovaries removed at 45 and are now 50, you are well within that window. If you are further out, systemic HRT is not ruled out, but the risks of stroke, clots and heart disease are higher, so your doctor will weigh your symptoms and health history more carefully and is more likely to suggest a patch or gel at a low dose.[1][7]

Low-dose vaginal estrogen for dryness and bladder symptoms can be used at any age and for as long as needed.[1]

Myth 11: “HRT prevents heart disease and dementia, so everyone should take it”

Fact: HRT is for symptoms and bone protection, not for preventing disease in general. This is the myth in the other direction. Despite the reassuring long-term data, guidelines do not recommend starting HRT just to prevent heart disease, dementia or other chronic illness.[1][3] In the WHI memory study, women who started estrogen alone at 65 or older did not have less dementia; the number of cases was, if anything, slightly higher, though the difference could have been due to chance.[9]

What HRT clearly does is relieve hot flashes and night sweats better than any other treatment, treat vaginal dryness, and prevent bone loss and fractures.[1] For women with early surgical menopause, replacing the estrogen the ovaries would still have been making also appears to reduce the long-term risks described in our hormones guide.

Who should not take HRT, or should be careful

Doctors are usually cautious or advise against systemic HRT if you have:[1]

  • Had breast cancer or another hormone-sensitive cancer.
  • Had a blood clot in a leg or lung, a stroke or a heart attack.
  • Active liver disease.
  • Vaginal bleeding that has not been explained.

Some of these rule out tablets but not necessarily a patch or vaginal estrogen, so it is worth a detailed conversation rather than a flat yes or no.

If you cannot or would rather not take hormones

Several non-hormonal treatments have good evidence for hot flashes: some antidepressants (SSRIs and SNRIs), gabapentin, and newer medicines that act on the brain’s temperature center, such as fezolinetant. Cognitive behavioral therapy and clinical hypnosis also help.[16] Many supplements sold for menopause, such as black cohosh or soy products, have not shown consistent benefit in trials. Our article on hot flashes and insomnia after hysterectomy covers these options in more detail.

Questions to take to your appointment

  • Were my ovaries removed, and does that change whether I should take estrogen?
  • Can I take estrogen alone, or do I need a progestogen because of endometriosis or my type of surgery?
  • Would a patch, gel or spray be safer for me than tablets?
  • Is anything in my personal or family history a reason to avoid HRT?
  • How long do you suggest I take it, and when should we review it?
  • Would low-dose vaginal estrogen help with dryness or bladder symptoms?

When to get medical help while taking HRT

Call 911 or go to the emergency room if you have sudden shortness of breath or chest pain, sudden weakness or numbness on one side, trouble speaking, a drooping face, or a sudden severe headache. These can be signs of a blood clot in the lung or a stroke.

Contact your doctor promptly if you notice:

  • Pain, swelling, warmth or redness in one leg.
  • A new breast lump, nipple change or skin dimpling.
  • Any vaginal bleeding, even without a uterus. See our guide to bleeding after hysterectomy.
  • Yellowing of the skin or eyes.

Frequently asked questions

Is HRT safer after a hysterectomy?

In one important way, yes. Without a uterus you can usually take estrogen alone, and in the largest randomized trial estrogen alone did not increase breast cancer or heart disease, unlike combined therapy.[3][5] The risks of stroke and blood clots still apply, especially with tablets and in older women.

I kept my ovaries. Should I take HRT now?

Usually not until you reach menopause and have symptoms that bother you. At that point, the same options apply as for any woman, with the advantage that estrogen alone is normally enough.

Do I need blood tests to set my HRT dose?

Generally no. Doses of FDA-approved products are adjusted according to how you feel. ACOG does not recommend the saliva tests and hormone panels often used to set the dose of compounded products.[10]

Can I stop HRT suddenly?

Stopping is not dangerous, but hot flashes may come back. Some women find it easier to reduce the dose gradually. Either way, plan it with your doctor.

Sources

  1. The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767–794. pubmed.ncbi.nlm.nih.gov
  2. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701–1712. pubmed.ncbi.nlm.nih.gov
  3. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013;310(13):1353–1368. pubmed.ncbi.nlm.nih.gov
  4. Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women’s Health Initiative randomized trials. JAMA. 2017;318(10):927–938. pubmed.ncbi.nlm.nih.gov
  5. Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women’s Health Initiative randomized clinical trials. JAMA. 2020;324(4):369–380. pubmed.ncbi.nlm.nih.gov
  6. Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019;394(10204):1159–1168. pubmed.ncbi.nlm.nih.gov
  7. Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews. 2015;(3):CD002229. pubmed.ncbi.nlm.nih.gov
  8. Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. pubmed.ncbi.nlm.nih.gov
  9. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA. 2004;291(24):2947–2958. pubmed.ncbi.nlm.nih.gov
  10. American College of Obstetricians and Gynecologists. Compounded bioidentical menopausal hormone therapy. ACOG Clinical Consensus No. 6. Obstetrics & Gynecology. 2023;142(5):1266–1273. pubmed.ncbi.nlm.nih.gov
  11. National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use. 2020. nap.edu
  12. Kongnyuy EJ, Norman RJ, Flight IHK, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviews. CD001018. cochrane.org
  13. U.S. Food and Drug Administration. HHS advances women’s health, removes misleading FDA warnings on hormone replacement therapy. November 10, 2025. fda.gov
  14. U.S. Food and Drug Administration. FDA approves labeling changes to menopausal hormone therapy products. February 12, 2026. fda.gov
  15. NHS. Types of hormone replacement therapy (HRT). nhs.uk
  16. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573–590. pubmed.ncbi.nlm.nih.gov

This article is for general information and is not a substitute for medical advice. Whether HRT is right for you depends on your surgery, age and personal and family history, so always discuss your own situation with your gynecologist or doctor, and contact them or emergency services if you are worried about any symptom.

Similar Posts